Company Profile

Developing therapies to improve kidney function and health-span in chronic kidney disease patients, Akpha young LLC is structured around organ preservation and biochemical signaling regulation. Management indicate strategy is seamlessly and comfortably to integrate into CKD treatment promoting improved health-span by restoring and stabilizing biological kidney functions. The firm;s approach is to ocus on preserving organs and organ functions that decline with age or as a result of illness and regulate hormone levels and other biochemical signaling between organs - with principals working to identify functional parts of specific functional proteins that may be modified to improve their therapeutic applications and provide patients with a longer health-span and a higher quality of life while awaiting a kidney transplant